Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | increases expression | EXP | | 6480464 | alpha phellandrene results in increased expression of NXT2 mRNA | CTD | PMID:25075043 | 1,2-dichloroethane | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NXT2 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | ISO | Nxt2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of NXT2 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of NXT2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nxt2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NXT2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NXT2 mRNA | CTD | PMID:33387578 | 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to NXT2 promoter] | CTD | PMID:20348232 | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of NXT2 mRNA | CTD | PMID:19194470 | 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of NXT2 mRNA | CTD | PMID:19194470 | acetamide | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of NXT2 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of NXT2 mRNA | CTD | PMID:28959563 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NXT2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NXT2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of NXT2 mRNA | CTD | PMID:33167477 | alpha-phellandrene | increases expression | EXP | | 6480464 | alpha phellandrene results in increased expression of NXT2 mRNA | CTD | PMID:25075043 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NXT2 5' UTR and Benzo(a)pyrene affects the methylation of NXT2 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of NXT2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | decreases methylation | ISO | Nxt2 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of NXT2 promoter | CTD | PMID:27312807 | cadmium sulfate | increases expression | EXP | | 6480464 | cadmium sulfate results in increased expression of NXT2 mRNA | CTD | PMID:21783983 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to NXT2 gene] | CTD | PMID:28238834 | copper atom | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of NXT2 mRNA | CTD | PMID:24690739 | copper(0) | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of NXT2 mRNA | CTD | PMID:24690739 | crocidolite asbestos | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of NXT2 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NXT2 mRNA | CTD | PMID:25562108 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of NXT2 mRNA | CTD | PMID:28302478 | disulfiram | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of NXT2 mRNA | CTD | PMID:24690739 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NXT2 mRNA | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of NXT2 mRNA | CTD | PMID:29391264 | ethanol | affects expression | ISO | Nxt2 (Mus musculus) | 6480464 | Ethanol affects the expression of NXT2 mRNA | CTD | PMID:30319688 | ethanol | affects splicing | ISO | Nxt2 (Mus musculus) | 6480464 | Ethanol affects the splicing of NXT2 mRNA | CTD | PMID:30319688 | fenthion | increases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Fenthion results in increased expression of NXT2 mRNA | CTD | PMID:34813904 | flutamide | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of NXT2 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | ISO | Nxt2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of NXT2 mRNA] | CTD | PMID:22206623 | glafenine | decreases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | Glafenine results in decreased expression of NXT2 mRNA | CTD | PMID:24136188 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of NXT2 mRNA | CTD | PMID:21179406 | isoprenaline | increases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of NXT2 mRNA | CTD | PMID:20003209 | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of NXT2 mRNA | CTD | PMID:31629900 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of NXT2 mRNA | CTD | PMID:28001369 | oxaliplatin | multiple interactions | ISO | Nxt2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NXT2 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Nxt2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NXT2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Nxt2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of NXT2 mRNA | CTD | PMID:33387578 | phenobarbital | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of NXT2 mRNA | CTD | PMID:19482888 | phenobarbital | affects expression | ISO | Nxt2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of NXT2 mRNA | CTD | PMID:23091169 | phenobarbital | increases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of NXT2 mRNA | CTD | PMID:19270015 | phenobarbital | multiple interactions | ISO | Nxt2 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of NXT2 mRNA] | CTD | PMID:19482888 | piroxicam | increases expression | EXP | | 6480464 | Piroxicam results in increased expression of NXT2 mRNA | CTD | PMID:21858171 | propiconazole | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | propiconazole results in decreased expression of NXT2 mRNA | CTD | PMID:21278054 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NXT2 mRNA | CTD | PMID:27188386 | silver atom | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Silver results in decreased expression of NXT2 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Silver results in decreased expression of NXT2 mRNA | CTD | PMID:27131904 | tetrachloromethane | decreases expression | ISO | Nxt2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of NXT2 mRNA | CTD | PMID:27339419 and PMID:31919559 | topotecan | multiple interactions | ISO | Nxt2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NXT2 mRNA | CTD | PMID:25729387 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of NXT2 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NXT2 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NXT2 mRNA | CTD | PMID:25979313 | versicolorin A | increases expression | EXP | | 6480464 | versicolorin A results in increased expression of NXT2 mRNA | CTD | PMID:32106047 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of NXT2 mRNA | CTD | PMID:27188386 | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of NXT2 mRNA | CTD | PMID:20977926 | |